CASE REPORT
A 45-year-old male patient sought medical attention because of a growing mass. The lesion was in the anterior cervical region initially, but over the last 2 years it also appeared in the occipital and dorsal regions. At the time of medical evaluation, the lesions caused him esthetic embarrassment. He also had type 2 diabetes mellitus and asymptomatic chronic pancreatitis. He had a history of alcoholic abuse of 1 liter/day for 10 years. He denied other comorbidities. He had worked as a bricklayer; however, due to the deformation caused by the masses, he was unemployed.
The physical evaluation revealed bulging masses of soft consistency in the anterior cervical region, in the pre-and post-auricular regions bilaterally, and on the back (Figure 1 ). The computed tomography imaging study showed a prominent unencapsulated excess of cervical adipose tissue (Figure 2A-C) . There was no sign of airway obstruction, hoarseness, cervical, or cervical venous engorgement. The mediastinum was not involved with the lipomatosis ( Figure 3D ).
A two-step surgical treatment was scheduled. In the first procedure, the anterior cervical mass was resected followed by closed vacuum system drainage. The occipital mass was resected with similar drainage after 1 month in a second surgery. In both surgeries, no dissection plan was identified between the adipose mass and the surrounding structures.
The anatomopathological study of the masses showed a mature adipocyte proliferation, which was compatible with lipomatosis.
Both procedures had a favorable outcome ( Figure 3 ) and after 1 year of follow-up the final esthetic result was satisfactory. After 1 year, the patient was able to look for employment.
DISCUSSION
MSL-which is called Madelung disease, Launois-Bensaude disease, or benign symmetrical lipomatosis-was first described by Benjamin Brodie in 1846, followed by reports by Madelung, and Launois and Bensaude, in 1898. MSL is a rare disease of fat metabolism. The subcutaneous unencapsulated fatty tissue overgrowth is painless and symmetrically involves mainly the head, neck, and upper torso, and eventually the upper extremities.
1 MSL typically presents between the third and the fifth decade of life and is more prevalent in males, 1, 2 with the male to female ratio ranging from 15:1 to 30:1. The disease is more common in the Mediterranean or in people with this ancestry than in the general population, and shows an incidence of 1:25,000 in the Italian population.
2
MSL does not have a completely defined pathophysiology. The adipogenesis is not a result of energy excess, but is an active proliferation of the adipose tissue. The suggested mechanisms comprise a defect of the respiratory chain, and deletions, and mutations of mitochondrial DNA. 3, 4 Lipomatous fat deposits may originate from functionally defective brown adipose tissue. 2 The tumor fatty cells have an anomalous metabolic behavior, which is characterized by a defect of the catecholamine's acute lipolytic action, and by the long-acting physiological mechanisms regulating lipid mobilization in adipose tissue.
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Alcoholic abuse is present in more than 90% of the cases. 9 A decrease in the beta-adrenergic receptors and disturbance in the mitochondrial DNA may be an explication of the pathogenic alcohol mechanism. 10 The history, epidemiology, and clinical features are the basis of MSL diagnosis. 10 However, the diagnosis, in some cases, may be challenging and frequently dismissed due to the high frequency of obesity. 1, 4 Patients with MSL often present concomitantly metabolic syndrome features as type 2 diabetes mellitus or glucose intolerance, hypertension, hyperlipidemia, and hyperuricemia. Diseases related to alcohol abuse, such as hepatopathy, macrocytic anemia, and peripheral neuropathy, are also common in MSL patients. 11 In 1984, Enzi 12 classified MSL into two types according to the site of the fat overgrowth. MSL type I is characterized by symmetric, circumscribed, protruding fat masses. The lesions can be predominantly distributed in the parotid glands (hamster cheeks), cervical region (horse collar), posterior neck (buffalo hump), submental region (Madelung collar), shoulders, supraclavicular triangle, and proximal upper limbs. In MSL type II, the lipomatous tissue is diffusely deposited in the subcutaneous tissue of the abdomen and thighs. The appearance resembles an obesity type of fat distribution. 10, 13 A congenital form, in which the lipomatosis deposition occurs around the trunk, was suggested by Carlsen and Thomsen 14 as type III. In 1991, Donhauser et al. 15 added the type III or gynecoid type to Enzi's classification, which became defined as relating to fat deposits mainly located in the pelvic region. 10, 16 Our patient was a middle-aged man-a heavy drinker-with lipomatosis restricted to the anterior and posterior neck, the parotid region, and the upper back torso; therefore, he represented MSL type I.
The malignant transformation of MSL is rare. [17] [18] [19] Complications are also rare and result from compression of the cervical structures by the fatty deposits causing dysphagia, 20 odynophagia, and hoarseness. Mediastinal and retroperitoneal lipomatosis can progress causing venous compression. 1, 21, 22 Imaging exams, such as computed tomography and magnetic resonance imaging, are useful for the evaluation of (i) the extension of the adipose tissue deposition; (ii) the tracheal compression; (iii) the presence of blood vessels within the adipose mass; and (iv) the malignant transformation. 1 The natural history of the disease shows progressive growth of the fat masses, with periods of rapid evolution (generally in the early stages of the disease), and periods of slow progression or a steady phase for a long period; however, no spontaneous regression occurs. 10 The differential diagnoses of MSL include obesity, Cushing syndrome, angiolipomatosis, encapsulated fibromas, neurofibromatosis, myxoid liposarcoma, lymphoma, salivary gland disease, Frölich syndrome, and lipomatosis in patients with HIV. 10, 23, 24 Although alcohol withdrawal and weight loss are recommended, these measures are not effective to reverse or to stop the progression of the disease. Currently, surgery is the only treatment available, so the removal of the fat masses remains the only therapy of choice. However, the overall recurrence rate is up to 63%.
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CONCLUSION
Despite the high recurrence rate, the surgical approach still needs to be considered. MSL causes not only biological disturbances, but also social loss (e.g. difficulty maintaining or acquiring a job)-the latter of which can be so deleterious that surgery is practically imperative.
The patient signed the informed consent declaration to permit the publication of this case report.
